Michael J. McKenna MD
Neurotology
Professor of Otolaryngology, Harvard Medical School
Join to View Full Profile
243 Charles StBoston, MA 02114
Phone+1 617-573-4458
Dr. McKenna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Otolaryngology - Head and Neck Surgery, 1984 - 1988
Huntington Memorial HospitalInternship, Transitional Year, 1982 - 1983
Keck School of Medicine of the University of Southern CaliforniaClass of 1982
Certifications & Licensure
CA State Medical License 1983 - Present
MA State Medical License 1989 - 2025
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology- American Board of Otolaryngology - Head and Neck Surgery Neurotology
Awards, Honors, & Recognition
- Vegas Seven Castle Connolly, 2014
- America's Top Doctors Castle Connolly, 2004-2014
- Boston Magazine Castle Connolly, 2008-2013
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsA century of exercise physiology: effects of muscle contraction and exercise on skeletal muscle Naconcentration-historical developments.,K-ATPase, Naand Kions, and on ...Michael J McKenna, Jean-Marc Renaud, Niels Ørtenblad, Kristian Overgaard
European Journal of Applied Physiology. 2024-03-01 - 2 citationsOtopathologic and Computed Tomography Correlation of Internal Auditory Canal Diverticula in Otosclerosis.Dawson Wells, Renata M Knoll, Elliott Kozin, Jenny X Chen, Katherine L Reinshagen
Otology & Neurotology. 2022-10-01 - 1 citationsComputed Tomography Density as a Bio-marker for Histologic Grade of Otosclerosis: A Human Temporal Bone Pathology Study.Alicia M Quesnel, Reuven Ishai, Timothy Meehan, Jennifer T O'Malley, Renee Mitchell
Otology & Neurotology. 2022-07-01
Press Mentions
Akouos Discloses Lead Program, AK-OTOF, a Potential Gene Therapy for Sensorineural Hearing LossSeptember 12th, 2019- Akouos Announces Executive Leadership Team AppointmentsSeptember 3rd, 2019
Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve HearingAugust 7th, 2018
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
